Novavax vaccine tested in Hartlepool is 89.3% effective and will be manufactured in Billingham
The NIHR-supported Novavax COVID-19 vaccine is 89.3% effective at preventing COVID-19, shown from interim analysis of its Phase III study data, including effectiveness against the new variants of concern.